Alkermes Plc (ALKS)
37.19
0.00 (0.00%)
USD |
NASDAQ |
May 19, 13:31
Alkermes Research and Development Expense (Quarterly) : 101.64M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amarin Corp. Plc | 4.020M |
| Xenon Pharmaceuticals, Inc. | 87.92M |
| Tyra Biosciences, Inc. | 33.33M |
| Spyre Therapeutics, Inc. | 60.41M |
| Agios Pharmaceuticals, Inc. | 79.78M |